Catalyst Wire Dossier Catalyst Wire Dossier

BT200

Rondaptivon Pegol
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BT200, covering 2021-11-11 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease [Phase 2]

See pricing